BioPharma Pharma & Biopharma Manufacturing
Vetter’s Rankweil Site Expands as Project Orders Surge, Completing First 100 Aseptic Batches
An increase in project orders drives further site growth The first 100 aseptic batches at Vetter’s Rankweil site predict a successful future The ...
September 06, 2024 | News
Exyte to Acquire TTP Group, Expanding Leadership in Europe's Biopharma Market
TTP Group is a leading engineering firm specializing in biotech and pharmaceutical industry The company serves blue-chip clients in Europe TTP Gr...
September 06, 2024 | News
The Critical Role of Chemistry, Manufacturing, and Control (CMC) in Pharmaceutical Product Development
The Development of new pharmaceutical products is a complex and multifaceted process that requires rigorous scientific, technical, and regulatory scrutiny....
August 09, 2024 | Opinion | By Vaibhav Patel, RAC-US, ASQ CQA Director of Quality Assurance and Regulatory Affairs, University of Minnesota
Merck Acquires Mirus Bio for $600M to Strengthen Viral Vector Manufacturing Solutions
Advances Merck’s ambition to provide fully integrated and comprehensive solution for viral vector manufacturing Mirus Bio’s leadin...
August 08, 2024 | News
Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
· Melbourne manufacturing site to be one of the most advanced pharmaceutical production facilities in Austr...
August 06, 2024 | News
Porton Advanced and Geneseed Biotech Forge Strategic Partnership to Accelerate circRNA Therapies
Porton Advanced Solutions ("Porton Advanced") announced that it had reached a strategic cooperation with Guangzhou Geneseed Biotech Co., Ltd ("Geneseed Bio...
July 31, 2024 | News
Pfizer Opens SGD$1 Billion Green Mark Gold-Certified API Manufacturing Facility in Singapore
Invests SGD$1 billion to produce small molecule APIs for oncology, pain, and antibiotic medicines The facility is Green Mark ‘Go...
July 23, 2024 | News
Agilent Acquires BIOVECTRA for $925 Million, Expanding Biopharma Capabilities
Agilent Technologies Inc. announced it has signed a definitive agreement to acquire BIOVECTRA, a leading specialized contract development and manufacturing...
July 23, 2024 | News
DiscGenics Receives FDA Approval to Proceed with Phase III Clinical Trials for Regenerative Cell Therapy for Lumbar Degenerative Disc Disease
DiscGenics, Inc., a privately held, late-stage clinical, biopharmaceutical company developing allogeneic, cell-based, regenerative therapies for musculoske...
July 23, 2024 | News
Everest Medicines Doses First Chinese Patient in Global Phase 2b Trial of Zetomipzomib for Lupus Nephritis
Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing an...
July 22, 2024 | News
ACROBiosystems Launches Resilient Supply Brand to Boost Cell and Gene Therapy Development at ISSCR Annual Meeting
At the recent International Society for Stem Cell Research (ISSCR) Annual Meeting in Hamburg, ACROBiosystems announced its new GMP-centered brand, Res...
July 19, 2024 | News
CordenPharma Announces €900 Million Investment to Expand Peptide Manufacturing Capabilities in US and Europe
CordenPharma has announced its largest strategic investment to date with a committed spend of ~€900m over the next 3 years to grow its Peptide technol...
July 17, 2024 | News
Sanyou Bio and Huadong Medicine Advance SYHD001 ADC Drug to Phase I Clinical Trials
Sanyou Biopharmaceuticals (Shanghai) Co., Ltd. (hereinafter referred to as "Sanyou Bio") has recently announced a significant milestone in collaboration wi...
July 17, 2024 | News
Everest Medicines Announces Positive Topline Data from Phase 3 Trial of Etrasimod for Ulcerative Colitis in Asia
Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing an...
July 16, 2024 | News
Most Read
- Bridging the Vision Gap: Roche’s Ahmed Elhusseiny on Eye Health Priorities in Asia Pacific
- How Merck’s India-Based Navi Mumbai Centre is Reimagining Formulation Science for the Global Generics Market
- Advancing Cell & Gene Therapy in APJ: How Thermo Fisher Enables Breakthrough Innovation
- AstraZeneca’s Vision for Chronic Kidney Disease: Sylvia Varela on Transforming CKD Care in Asia
- ACG Leads the Charge in Vegan Capsules: Innovation, Certification, and the Future of Sustainable Pharma
- ORA’s Hybrid Model Reshapes Obesity Care: Dr. Ben Ng on Bridging Telehealth and In-Person Treatment
- Heather Hargett on How Merck’s HUB Organoids Acquisition is Reshaping 3D Cell Culture and Drug Development
- Health2Sync's Vision for Diabetes Care: Transforming Outcomes Through Technology and Partnerships
Bio Jobs
- Ravindra Rao Joins GOBI Technologies as Director of Life Sciences – APAC
- Amgen Announces $900 Million Expansion of Ohio Biomanufacturing Facility, Boosting Investment to Over $1.4 Billion
- Thermo Fisher Scientific Appoints Former CVS Health CEO Karen S. Lynch to Board of Directors
- Merck KGaA Reshapes Leadership for the Future with Key Executive Moves
- Aarian Health Appoints Thomas Keller as Business Director to Drive Innovation and Growth
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
News
Editor Picks
